Biotransformation and toxicity of the lipoxygenase inhibitor 2-hydroxy-5-methyllaurophenone oxime (FLM 5011) on hep G2 cells

Archiv der Pharmazie

Volumn 331, Issue 7-8, 1998, Pages 259-261

  Mühlenfeld, Katrin ^a   Langner, Andreas ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Apoptosis; Cytotoxicity; FLM 5011; Lipoxygenase

Indexed keywords

2 HYDROXY 5 METHYLLAUROPHENONE OXIME; FLM 5011; LIPOXYGENASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOTOXICITY; DRUG METABOLISM; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BIOTRANSFORMATION; CELL DIVISION; CELL LINE; DNA; ELECTROPHORESIS, AGAR GEL; HUMANS; LAURIC ACIDS; LIPOXYGENASE INHIBITORS; LIVER; OXIMES; RATS; TUMOR CELLS, CULTURED;

EID: 0031872868     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4184(199807)331:7/8<259::AID-ARDP259>3.0.CO;2-7     Document Type: Article

References (6)

1. T. Schewe, H. Kühn, S. Loose, L.Lücke in Prostaglandins, leukotrienes, lipoxines and PAF, New York, 1991, p 383.
2. A. Langner, C. Rentsch, C. Nehrlich, I. Rittner, H. Kühn, T. Schewe, P. Franke, Pharmazie 1996, 51, 403.
3. I. Vermes, C. Haanen, H. Steffens-Nakken, C. Reutelingsperger, J. Immunol. Meth. 1995, 184, 39.
4. D.G. Tang, Y.Q. Chen, K.V. Honn, Proc. Natl. Acad. Sci. USA 1996, 93, 5241-5246.
5. I.M. Avis, M. Jett, T. Boyle, M.D. Vos, T. Moody, A.M. Treston, A. Martinez, J.L. Mulshine, J. Clin. Invest. 1996, 97, 806-813.
6. J. Schulz, S. Dettlaff, U. Fritzsche, U. Harms, H. Schiebel, W. Dere, N. Fusenig, A. Hülsen, M. Böhm, J. Immunol. Meth. 1994, 167, 1-13.